Literature DB >> 218754

Plasma ACTH and cortisol profiles in Addisonian patients receiving conventional substitution therapy.

R S Scott, R A Donald, E A Espiner.   

Abstract

Plasma ACTH and cortisol profiles were studied over 24 h in five Addisonian patients maintained in good health by conventional gluco- and mineralocorticoid treatment. Patients received their usual treatment (15--30 mg cortisol daily) in divided doses at 08.00 and 16.00 hours. Plasma cortisol concentrations differed from those of control subjects in being higher from 08.00 hours-noon and 17.00-18.00 hours and were unmeasurable (less than 20 nmol/l) during the period of active cortisol secretion (03.00-08.00 hours) observed in normal subjects. Peak plasma ACTH levels (618- greater than 1600 ng/l) occurred at 08.00-09.00 hours in the Addisonian patients and were much greater than those seen in control subjects (60-220 ng/l). Despite this, plasma ACTH fell promptly within 3 h of the morning dose to less than 100 ng/l and levels were indistinguishable from those seen in normal subjects over the period 12.00-02.00 hours. These results show that there are substantial differences between treated Addisonian and control subjects in respect of plasma cortisol and ACTH concentrations. The findings may lead to a better understanding of ACTH-cortisol relationships in disease states, including congenital adrenal hyperplasia where control of excessive ACTH secretion is clinically desirable.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 218754     DOI: 10.1111/j.1365-2265.1978.tb01516.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  11 in total

1.  Bilateral adrenocortical adenomas causing ACTH-independent Cushing's syndrome at different periods: a case report and discussion of corticosteroid replacement therapy following bilateral adrenalectomy.

Authors:  S C Tung; P W Wang; T L Huang; W C Lee; W J Chen
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

2.  The diurnal rhythm of adrenocorticotropic hormone secretion in the assessment of the adequacy of replacement therapy in primary chronic adrenal failure.

Authors:  V V Fadeev; E P Gitel; G A Mel'nichenko
Journal:  Neurosci Behav Physiol       Date:  2001 May-Jun

3.  GH-releasing peptide (GHRP-6)-induced ACTH release in patients with addison's disease: effect of glucocorticoid withdrawal.

Authors:  M R A Martins; A C A R Pinto; E Brunner; M R D Silva; A M J Lengyel
Journal:  J Endocrinol Invest       Date:  2003-02       Impact factor: 4.256

4.  Improvement of treatment of primary adrenal insufficiency by administration of cortisone acetate in three daily doses.

Authors:  S Laureti; A Falorni; F Santeusanio
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

5.  Plasma cortisol delivery from oral cortisol and cortisone acetate: relative bioavailability.

Authors:  V J Heazelwood; J P Galligan; G R Cannell; F Bochner; R H Mortimer
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

6.  Pituitary Corticotroph Adenoma in a Woman with Long-Standing Addison's Disease: A Histologic, immunocytochemical, Electron Microscopic, and In Situ Hybridization Study.

Authors:  Kalman Kovacs; Lucia Stefaneanu; Eva Horvath; Michael Buchfelder; Rudolph Fahlbusch; Peter H. Althoff; Christine Moore
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

Review 7.  Therapy of adrenal insufficiency: an update.

Authors:  Alberto Falorni; Viviana Minarelli; Silvia Morelli
Journal:  Endocrine       Date:  2012-11-21       Impact factor: 3.633

8.  Corticosteroid replacement therapy: twice or thrice daily?

Authors:  R W Groves; G C Toms; B J Houghton; J P Monson
Journal:  J R Soc Med       Date:  1988-09       Impact factor: 18.000

9.  Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency.

Authors:  Elise Rousseau; Michael Joubert; Géraldine Trzepla; Jean Jacques Parienti; Thomas Freret; Marie Christine Vanthygem; Rachel Desailloud; Hervé Lefebvre; Antoine Coquerel; Yves Reznik
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

10.  Subcutaneous pulsatile glucocorticoid replacement therapy.

Authors:  Georgina M Russell; Claire Durant; Alia Ataya; Chrysoula Papastathi; Ragini Bhake; Wolfram Woltersdorf; Stafford Lightman
Journal:  Clin Endocrinol (Oxf)       Date:  2014-05-19       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.